"pharmacokinetics of andrographolide in rats" trang 4 - tải miễn phí từ tailieuXANH
Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania

Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania
9    51    0
First-in-human study assessing safety, tolerability, and pharmacokinetics of 2- hydroxybenzylamine acetate, a selective dicarbonyl electrophile scavenger, in healthy volunteers

First-in-human study assessing safety, tolerability, and pharmacokinetics of 2- hydroxybenzylamine acetate, a selective dicarbonyl electrophile scavenger, in healthy volunteers
6    44    0
Identification of cryptolepine metabolites in rat and human hepatocytes and metabolism and pharmacokinetics of cryptolepine in Sprague Dawley rats

Identification of cryptolepine metabolites in rat and human hepatocytes and metabolism and pharmacokinetics of cryptolepine in Sprague Dawley rats
9    49    0
Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/ extended-release hydrocodone bitartrate/ acetaminophen (MNK-155) under fed and fasted conditions: Two randomized open-label trials

Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/ extended-release hydrocodone bitartrate/ acetaminophen (MNK-155) under fed and fasted conditions: Two randomized open-label trials
10    33    0
Population pharmacokinetic and pharmacodynamic modeling of transformed binary effect data of triflusal in healthy Korean male volunteers: A randomized, open-label, multiple dose, crossover study

Population pharmacokinetic and pharmacodynamic modeling of transformed binary effect data of triflusal in healthy Korean male volunteers: A randomized, open-label, multiple dose, crossover study
10    42    0
CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe

CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe
10    71    0
The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects

The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects
12    44    0
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: Results from an open-label and from a randomised study

Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: Results from an open-label and from a randomised study
11    52    0
Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus

Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus
11    42    0
Study of gender-related pharmacokinetics of ezogabine in Egyptian volunteers by a validated LC-MS/MS bioanalytical method

Study of gender-related pharmacokinetics of ezogabine in Egyptian volunteers by a validated LC-MS/MS bioanalytical method
6    50    0
The population pharmacokinetics of D-β-hydroxybutyrate following administration of (R)-3-Hydroxybutyl (R)-3-hydroxybutyrate

The population pharmacokinetics of D-β-hydroxybutyrate following administration of (R)-3-Hydroxybutyl (R)-3-hydroxybutyrate
11    139    0
Development of solid self-emulsifying formulation for improving the oral bioavailability of erlotinib

Development of solid self-emulsifying formulation for improving the oral bioavailability of erlotinib
8    53    0
Pharmacokinetics and tissue residue study of levofloxacin following multiple dose intramuscular administration in poultry

Pharmacokinetics and tissue residue study of levofloxacin following multiple dose intramuscular administration in poultry
5    53    0
The pharmacokinetics, bioavailability and excretion of bergapten after oral and intravenous administration in rats using high performance liquid chromatography with fluorescence detection

The pharmacokinetics, bioavailability and excretion of bergapten after oral and intravenous administration in rats using high performance liquid chromatography with fluorescence detection
8    45    0
Determination of parecoxib and valdecoxib in rat plasma by UPLC-MS/MS and its application to pharmacokinetics studies

Determination of parecoxib and valdecoxib in rat plasma by UPLC-MS/MS and its application to pharmacokinetics studies
10    60    0
Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole

Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
9    99    0
Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: A validation study for the theranostic approach using [18F]-L-FBPA positron emission tomography in boron neutron capture therapy

Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: A validation study for the theranostic approach using [18F]-L-FBPA positron emission tomography in boron neutron capture therapy
10    60    0
A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers

A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers
13    65    0
Utilizing native fluorescence imaging, modeling and simulation to examine pharmacokinetics and therapeutic regimen of a novel anticancer prodrug

Utilizing native fluorescence imaging, modeling and simulation to examine pharmacokinetics and therapeutic regimen of a novel anticancer prodrug
10    70    0
Different types of smart nanogel for targeted delivery

Different types of smart nanogel for targeted delivery
12    55    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.